Latest News and Press Releases
Want to stay updated on the latest news?
-
- Record quarterly revenues increase 12% to $30.7 million - GAAP earnings per share increase 9% to $0.18 - Raising bottom-end of 2014 revenue guidance range to $123 million from $121 million,...
-
MINNEAPOLIS, July 3, 2014 (GLOBE NEWSWIRE) -- On May 23, 2014, Vascular Solutions, Inc. (Nasdaq:VASC) initiated a voluntary nationwide recall of Langston dual lumen catheters used in catheterization...
-
MINNEAPOLIS, July 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its second quarter conference call on Tuesday, July 22nd at...
-
- Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors - Designed for use by interventional radiologists who currently use microspheres, PVA particles,...
-
MINNEAPOLIS, May 1, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2014 Health Care...
-
Record revenues increase 15% to $29.9 million, reflecting growth in all three product categories EPS increases 26% to $0.16, including above-budget legal expenses that reduced first quarter...
-
- U.S. Army will sponsor, conduct and fund all Food and Drug Administration (FDA) required pre-clinical and clinical studies of the freeze-dried plasma product developed by Vascular Solutions -...
-
MINNEAPOLIS, April 15, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced that a three judge panel of the U.S. Court of Appeals for the Federal Circuit today vacated the...
-
-- Reprocessing of popular vein treatment catheter results in significant cost savings and reduced medical waste for U.S. vein clinics -- Excellent safety record established, with no serious...
-
MINNEAPOLIS, April 8, 2014 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its first quarter conference call on Tuesday, April 22nd at...